[go: up one dir, main page]

PT1499610E - Derivados de benzopirano substituídos com aminas secundárias incluindo tetrazole, método para a sua preparação e composições farmacêuticas que os contêm - Google Patents

Derivados de benzopirano substituídos com aminas secundárias incluindo tetrazole, método para a sua preparação e composições farmacêuticas que os contêm Download PDF

Info

Publication number
PT1499610E
PT1499610E PT03713069T PT03713069T PT1499610E PT 1499610 E PT1499610 E PT 1499610E PT 03713069 T PT03713069 T PT 03713069T PT 03713069 T PT03713069 T PT 03713069T PT 1499610 E PT1499610 E PT 1499610E
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
secondary amines
amines including
Prior art date
Application number
PT03713069T
Other languages
English (en)
Inventor
Hong Lim
Dong-Ha Lee
Sun-Ok Kim
In-Young Choi
Sung-Eun Yoo
Kyu-Yang Yi
Sun-Kyung Lee
Jee-Hee Suh
Nak-Jeong Kim
Byung-Ho Lee
Ho-Won Seo
Hwa-Sup Shin
Original Assignee
Dongbu Hitek Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongbu Hitek Co Ltd filed Critical Dongbu Hitek Co Ltd
Publication of PT1499610E publication Critical patent/PT1499610E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrane Compounds (AREA)
PT03713069T 2002-04-10 2003-04-10 Derivados de benzopirano substituídos com aminas secundárias incluindo tetrazole, método para a sua preparação e composições farmacêuticas que os contêm PT1499610E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20020019460 2002-04-10

Publications (1)

Publication Number Publication Date
PT1499610E true PT1499610E (pt) 2009-04-29

Family

ID=28786915

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03713069T PT1499610E (pt) 2002-04-10 2003-04-10 Derivados de benzopirano substituídos com aminas secundárias incluindo tetrazole, método para a sua preparação e composições farmacêuticas que os contêm

Country Status (18)

Country Link
US (1) US7414068B2 (pt)
EP (1) EP1499610B1 (pt)
JP (1) JP4237639B2 (pt)
KR (1) KR100526119B1 (pt)
CN (1) CN100503602C (pt)
AR (1) AR039283A1 (pt)
AT (1) ATE421513T1 (pt)
AU (1) AU2003218824A1 (pt)
BR (1) BR0309239A (pt)
CA (1) CA2481707C (pt)
DE (1) DE60325956D1 (pt)
ES (1) ES2318118T3 (pt)
HK (1) HK1074048A1 (pt)
MX (1) MXPA04009747A (pt)
PT (1) PT1499610E (pt)
RS (1) RS50905B (pt)
RU (1) RU2283312C2 (pt)
WO (1) WO2003084464A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100492252B1 (ko) * 2002-08-09 2005-05-30 한국화학연구원 이미다졸을 포함하는 이차아민으로 치환된 벤조피란유도체 및 그의 제조방법
KR100545780B1 (ko) * 2003-05-28 2006-01-24 동부한농화학 주식회사 벤즈이미다졸 유도체로 치환된 벤조피란 유도체 또는약학적으로 허용되는 그의 염, 이의 제조 방법 및 이를포함하는 약학적 조성물
JP5150091B2 (ja) * 2006-11-01 2013-02-20 日本澱粉工業株式会社 低酸素状態下での細胞及び心臓保存剤
US20140018402A1 (en) * 2011-03-30 2014-01-16 Catholic University Industry Academic Cooperation Foundation Pharmaceutical composition for preventing or treating macular degeneration
ES2562472T3 (es) * 2011-06-29 2016-03-04 Basf Se Uso de aminocarboxilatos en la agricultura
KR102484846B1 (ko) * 2015-11-27 2023-01-05 한림제약(주) 벤조피란 유도체의 정제방법, 이의 결정형 및 상기 결정형의 제조방법
SG10202100751YA (en) * 2016-07-29 2021-03-30 Sunovion Pharmaceuticals Inc Compounds and compositions and uses thereof
EA201990400A1 (ru) 2016-07-29 2019-07-31 Суновион Фармасьютикалз, Инк. Соединения и композиции и их применение
SG11202000669VA (en) 2017-08-02 2020-02-27 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof
CA3130849A1 (en) 2019-03-14 2020-09-17 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4841078A (en) * 1982-03-16 1989-06-20 Pfizer Inc. Benzopyrans
AU651105B2 (en) * 1990-06-18 1994-07-14 E.R. Squibb & Sons, Inc. Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
GB9413407D0 (en) * 1994-07-04 1994-08-24 Redrock Eng Ltd Improved mixing and discharging apparatus for materials such as silage
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
JP4761683B2 (ja) * 1999-06-04 2011-08-31 ユーロ−セルティック エス. ア. 置換5−オキソ−5,6,7,8−テトラヒドロ−4h−1−ベンゾピランおよびベンゾチオピランならびにそのampa増強剤としての使用
DE60024120T2 (de) * 1999-08-26 2006-07-27 Aventis Pharmaceuticals Inc. Substituierte (aminoiminomethyl oder aminomethyl) dihydrobenzofurane und benozopyrane
US6323238B1 (en) * 1999-10-21 2001-11-27 Dongbu Hannong Chemical Co., Ltd. Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
KR100429609B1 (ko) * 1999-10-21 2004-05-03 동부한농화학 주식회사 벤조피라닐 구아니딘 유도체, 그의 제조방법 및 그를포함하는 약학적 조성물

Also Published As

Publication number Publication date
CN100503602C (zh) 2009-06-24
BR0309239A (pt) 2005-02-15
RU2283312C2 (ru) 2006-09-10
ES2318118T3 (es) 2009-05-01
US20060035948A1 (en) 2006-02-16
JP2005529863A (ja) 2005-10-06
AU2003218824A8 (en) 2003-10-20
RU2004132869A (ru) 2005-06-10
CA2481707C (en) 2010-09-28
EP1499610A4 (en) 2006-05-24
WO2003084464A2 (en) 2003-10-16
ATE421513T1 (de) 2009-02-15
CA2481707A1 (en) 2003-10-16
EP1499610A2 (en) 2005-01-26
DE60325956D1 (de) 2009-03-12
HK1074048A1 (en) 2005-10-28
JP4237639B2 (ja) 2009-03-11
RS50905B (sr) 2010-08-31
EP1499610B1 (en) 2009-01-21
MXPA04009747A (es) 2004-12-13
AU2003218824A1 (en) 2003-10-20
AR039283A1 (es) 2005-02-16
RS27803A (en) 2007-02-05
CN1646524A (zh) 2005-07-27
WO2003084464A3 (en) 2003-11-27
US7414068B2 (en) 2008-08-19
KR20030081149A (ko) 2003-10-17
KR100526119B1 (ko) 2005-11-08

Similar Documents

Publication Publication Date Title
IL158784A (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives, processes for their preparation and pharmaceutical compositions containing them
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
HK1167332A1 (en) Pharmaceutical composition, use thereof and method for making the same
IL164798A0 (en) Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
IL173195A0 (en) Cyclovinylazoline derivatives, their preparation and pharmaceutical compositions containing them
HK1123789A1 (en) Azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
HK1081964A1 (en) Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same
IL169818A0 (en) Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
IL169500A0 (en) Pyrrolopyridazine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
MXPA03006538A (es) Nuevos derivados de urea, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion.
HK1099748A1 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
HK1074048A1 (en) Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
IL163643A0 (en) Oxazolidinone derivatives, processes for their forpreparation, and pharmaceutical compositions containing them
HUP0401018A3 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
AU2003231920A8 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
PL374761A1 (en) N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
HK1081191A1 (en) 3-(4-Oxo-4H-chromen-2-yl)-(1H)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same
EP1711490A4 (en) P-GLYCOPROTEIN INHIBITOR, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
PL1655030T3 (pl) Pochodne benzotiadiazyny, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
SI1245565T1 (en) Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
SI1241169T1 (en) Isoindoloindolone derivatives, process for their preparation and pharmaceutical compositions containing them
EP1515960A4 (en) 2-THIOXOTHIAZOL DERIVATIVE, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
AU2003232684A8 (en) Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same
SI1413579T1 (en) Imidazoline derivatives, process for the preparation thereof and pharmaceutical compositions containing them